Dr. Radhakrishnan brings significant experience in product development and commercialization that will be particularly ...

ADMA rises on strong Asceniv demand and boosted 2025-2026 guidance. However, valuation warrants investor caution.

New data from the IRAKLIA and IZALCO trials, presented at the 2025 ASCO Annual Meeting, demonstrate that subcutaneous ...

Vera Therapeutics (VERA) stock faces a 32% drop as its IgAN drug trails Otsuka's (ORSKY) rival in late-stage trials. Read ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Sarepta Therapeutics’ gene therapy to treat limb girdle muscular dystrophy type 2E/R4 gets US FDA platform technology designation: Cambridge, Massachusetts Friday, June 6, 2025, ...

India had the early mover's advantage when it came to developing a suo-motu legislation to protect and manage its ...

China NMPA accepts Hutchmed & Innovent’s NDA for fruquintinib in combo with sintilimab to treat advanced renal cell carcinoma: Hong Kong, Shanghai Friday, June 6, 2025, 09:00 Hr ...

It was the first major dispute over the National Environmental Policy Act before the Supreme Court in 20 years.

The EIA is an integral (high-profile) component of regulatory process that has evolved over the last couple of decades to ...

The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.